Drug name: MT110


Related CSCTT Targets

EpCAM [ref.1]P16422

EpCAM/CD3-bispecific antibody MT110

Cas.no PubChem ID
Not Detected Not Detected
Known Target
EpCAMP16422
CD3P04234
Introduction
MT110 is a bispecific T-cell–engaging (BiTE) antibody construct, which simultaneously targets EpCAM on tumor cells and the T-cell receptor–CD3 complex on T cells.

EpCAM/CD3-bispecific antibody MT110-Structure

...

Reference

  • [1] EpCAM/CD3-Bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells.
    Cioffi, M., et al. (2012). Clin Cancer Res 18(2): 465-474. [ 22096026 ]

Back to top